Navigation Links
Drug Combo Works Better for children with ADHD, Tics

Drug Combo may be the best method for tackling a irksome duo: attention deficit hyperactivity disorder (ADHD) combined with a chronic twitching disorder. New research suggests that mixing// two of the most commonly prescribed drugs for ADHD is the most effective therapy for kids who struggle with a combination of ADHD and muscular control disorders.

Various studies have shown that between 21 percent and 90 percent of children with a tic disorder also have ADHD. This combination has given a unique therapeutic problem because the unanimity has been that Ritalin – the most commonly used drug for treating ADHD's symptoms– is a stimulant, and stimulants were thought to worsen tics. But so far, there has been no evidence proving this to be true. Hoping to lay this question to rest, researchers set out to study the most effective drug therapy for children with this combination of disorders.

In the study, 136 children with both ADHD and a chronic tic disorder were divided into four groups. While one group received a placebo, a second received Ritalin, a third received clonidine, and a fourth received a combination of the two drugs. The biggest reductions in ADHD symptoms were seen in children taking both clonidine and Ritalin. About 85 percent showed improvement. And when it came to reducing the severity of a child's tic symptoms, the most effective treatment also appeared to be a combination of Ritalin and clonidin.
'"/>




Page: 1

Related medicine news :

1. Scanning Combo Helps Detect Lung Cancer
2. Relief From Asthma With New Combo Therapy
3. Calcium-Vitamin D Combo For Reduced Fracture Risk
4. Drug Combo Improves Performance Of Multiple Sclerosis Drug
5. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
6. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
7. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
8. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
9. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
10. Fuzeon and MK-0518 Combo Holds Promise For HIV
11. Germ - Chemo Combo Fights Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... 2017 , ... Much attention has been paid to the problem of men ... painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain medications ... in male populations.(1) , The proportion of women using illicit drugs is also increasing ...
(Date:2/27/2017)... ... ... Orange County dentist, Dr. A. Rassouli, comments on the new ... bacteria in plaque infect the gums and other tissues supporting the teeth. Treatment typically ... SRP, and can include surgical therapies if the condition has led to significant damage. ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon ... proud to announce a new informational post on robotic hair transplantation. San Francisco ... (FUE) hair transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment ...
(Date:2/26/2017)... (PRWEB) , ... February 25, 2017 , ... The February ... Jong-un, heightened awareness and concern over nerve agents and the deadly use of chemical ... human nervous system and how even small doses can be lethal. , Jay Jagannathan, ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... Fourth-quarter 2016 revenues of $1,242 million brings ... of guidance Company reports ... associated with the write-down of goodwill and intangible assets ... Fourth-quarter reported $14.96 diluted (GAAP) ... $14.48 diluted (GAAP) loss per share from continuing operations ...
(Date:2/27/2017)... Halyard Health, Inc. (NYSE: HYH ) ... its 2017 outlook and related key planning assumptions. Executive Summary ... a 2 percent increase compared to the prior year. ... $10 million compared to net income of $15 million in ... was $24 million compared to adjusted net income of $27 ...
(Date:2/27/2017)... 27, 2017  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), ... molecular diagnostic tests and pathology services, announced today the ... upcoming United States and Canadian ... 2017 in San Antonio, Texas . ... data from the Company,s extensive experience in molecular thyroid ...
Breaking Medicine Technology: